Catalysts for Baxter Healthcare Corp
370 tracked
Apr 20, 2026
drug shortage
Ketorolac Tromethamine Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Dextrose Monohydrate 70% Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Dextrose Monohydrate 10% Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Rocuronium Bromide Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Lidocaine Hydrochloride Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Clindamycin Phosphate Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Dexmedetomidine Hydrochloride Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Furosemide Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Dobutamine Hydrochloride Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Sterile Water Irrigant shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Amino Acid Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Dextrose Monohydrate 5% Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Dopamine Hydrochloride Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Heparin Sodium Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 20, 2026
drug shortage
Metronidazole Injection shortage — Baxter Healthcare
Baxter Healthcare Corp
→
Apr 15, 2026
recall
Fagron Compounding Services recall (Cls II)
Baxter Healthcare Corp
→
Apr 15, 2026
recall
Fagron Compounding Services recall (Cls II)
Baxter Healthcare Corp
→
Apr 15, 2026
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Apr 3, 2026
grant
WAYNE STATE UNIVERSITY — Mechanisms underlying Phage-Antibiotic Synergy and Resistance in Daptomycin-R...
Baxter Healthcare Corp
→
Apr 3, 2026
approval
PHENYLEPHRINE HYDROCHLORIDE — FDA approval
PHENYLEPHRINE HYDROCHLORIDE
→
Mar 30, 2026
approval
EPINEPHRINE — FDA approval
adrenaline
→
Mar 10, 2026
approval
DOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approval
Doxil
→
Feb 26, 2026
approval
PHYTONADIONE — FDA approval
PHYTONADIONE
→
Feb 18, 2026
device recall
Baxter Healthcare Corporation device recall (Cls II)
Baxter Healthcare Corp
→
Feb 18, 2026
device recall
Baxter Healthcare Corporation device recall (Cls I)
Baxter Healthcare Corp
→
Feb 6, 2026
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Feb 4, 2026
recall
Baxter Healthcare Corporation recall (Cls II)
Baxter Healthcare Corp
→
Jan 16, 2026
device 510k
Baxter Healthcare Corp/ Excel Medical — WAVE Clinical Platform (2.0.000) (510k cleared)
Baxter Healthcare Corp
→
Jan 13, 2026
device recall
Baxter Healthcare Corporation device recall (Cls II)
Baxter Healthcare Corp
→
Jan 8, 2026
approval
MAGNESIUM SULFATE — FDA approval
MAGNESIUM SULFATE
→